A Multicenter and Randomized Controlled Trial of Bicyclol in the Treatment of Statin-Induced Liver Injury
暂无分享,去创建一个
J. Li | Zhu Chenggang | N. Wu | Liang Jianjun | Yanjun Zhou | W. Liansheng | Han Zhan-ying | C. Zhu | Yuan-fang Guo | Wu Naqiong | Guo Yuanlin | Gao Ying | Dong Qian | Liu Dongchen | Zhou Yanjun | Liansheng Wang | Z. Han | Dongrui Liu | Cheng-gang Zhu | Yanjun Zhou
[1] W. Cong,et al. CSH guidelines for the diagnosis and treatment of drug-induced liver injury , 2017, Hepatology International.
[2] Feng-jie Qi,et al. Protective Role of Grape Seed Proanthocyanidins Against Ccl4 Induced Acute Liver Injury in Mice , 2016, Medical science monitor : international medical journal of experimental and clinical research.
[3] J. Jose. Statins and its hepatic effects: Newer data, implications, and changing recommendations , 2016, Journal of pharmacy & bioallied sciences.
[4] Xin Fu,et al. Single-Dose Local Simvastatin Injection Improves Implant Fixation via Increased Angiogenesis and Bone Formation in an Ovariectomized Rat Model , 2015, Medical science monitor : international medical journal of experimental and clinical research.
[5] H-P Xiao,et al. Role of bicyclol in preventing drug-induced liver injury in tuberculosis patients with liver disease. , 2015, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[6] Mao-rong Wang,et al. [RUCAM scale-based diagnosis, clinical features and prognosis of 140 cases of drug-induced liver injury]. , 2014, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.
[7] T. Jacobson. NLA Task Force on Statin Safety--2014 update. , 2014, Journal of clinical lipidology.
[8] J. Ge,et al. Managing hypercholesterolemia and preventing cardiovascular events in elderly and younger Chinese adults: focus on rosuvastatin , 2013, Clinical interventions in aging.
[9] [Experts consensus of the evaluation on the statin drugs safty]. , 2014, Zhonghua xin xue guan bing za zhi.
[10] Jennifer G. Robinson,et al. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , 2014, Journal of the American College of Cardiology.
[11] Dong Joon Kim,et al. Drug-induced liver injury: present and future , 2012, Clinical and molecular hepatology.
[12] Q. Xie,et al. [Clinical and pathological features in 138 cases of drug-induced liver injury]. , 2012, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.
[13] B. Tomlinson,et al. Safety of statins: an update , 2012, Therapeutic advances in drug safety.
[14] Hye‐Ryun Kang,et al. Spontaneously Reported Hepatic Adverse Drug Events in Korea: Multicenter Study , 2012, Journal of Korean medical science.
[15] Evangelos Kalaitzakis,et al. Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing. , 2012, Journal of hepatology.
[16] Z. Lang,et al. A randomized, multi-central, controlled study of patients with hepatitis B e antigen-positive chronic hepatitis B treated by adefovir dipivoxil or adefovir dipivoxil plus bicyclol , 2011, Hepatology International.
[17] R. Collins,et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials , 2010, The Lancet.
[18] L. Cubeddu,et al. Statins in the treatment of dyslipidemia in the presence of elevated liver aminotransferase levels: a therapeutic dilemma. , 2010, Mayo Clinic proceedings.
[19] Geng-tao Liu. Bicyclol: a novel drug for treating chronic viral hepatitis B and C. , 2009, Medicinal chemistry (Shariqah (United Arab Emirates)).
[20] K. Tajiri,et al. Practical guidelines for diagnosis and early management of drug-induced liver injury. , 2008, World journal of gastroenterology.
[21] Wei Jiang,et al. Clinical analysis of 275 cases of acute drug-induced liver disease , 2007, Frontiers of medicine in China.
[22] Huiping Wang,et al. Protective effect of bicyclol on acute hepatic failure induced by lipopolysaccharide and D-galactosamine in mice. , 2006, European journal of pharmacology.
[23] H. Krumholz,et al. Risks Associated With Statin Therapy: A Systematic Overview of Randomized Clinical Trials , 2006, Circulation.
[24] Yan Li,et al. Mechanism of protective action of bicyclol against CCl4‐induced liver injury in mice , 2005, Liver international : official journal of the International Association for the Study of the Liver.
[25] T. Yano,et al. Apoptotic injury in cultured human hepatocytes induced by HMG-CoA reductase inhibitors. , 2004, Biochemical pharmacology.
[26] G. Danan,et al. Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. , 1993, Journal of clinical epidemiology.